Metabolomics in asthma: where do we stand?

doi:10.1097/MCP.0000000000000437

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Metabolomics in asthma: where do we stand?

Current opinion in pulmonary medicine - 1 Jan 2018

Pité Helena, Morais-Almeida Mário, Rocha Sílvia M

Abstract excerpt

PURPOSE OF REVIEW: Metabolomics has been used to uncover the metabolic signatures of asthma, both for biomarker identification and pathophysiologic mechanisms research. We aimed to review recent advances in this field, published since 2016, and discuss these findings implications to future research and application into clinical practice. RECENT FINDINGS: Experimental asthma models and clinical studies in both...

Topics

Adrenal Cortex Hormones
Asthma
Biomarkers
Exhalation
Humans
Metabolomics
Obesity
Phenotype
Predictive Value of Tests
Purines
Volatile Organic Compounds

Source

Open in PubMed

Identifiers

PMID: 29059088
DOI: 10.1097/MCP.0000000000000437

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics